Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogen therapy helps treat genetic hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Combination therapy of doxazosin and finasteride safely and effectively reduces benign prostatic hyperplasia progression risk.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Certain drugs that block specific enzymes can help treat prostate diseases.

Use minoxidil for hair loss treatment, and finasteride for men.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Finasteride effectively treats male hair loss, increasing length and thickness.

Saw palmetto extract is generally safe and can effectively treat Lower Urinary Tract Symptoms, but its evaluation is affected by varying quality and a need for long-term studies.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Tadalafil is effective for treating urinary symptoms in men with BPH.

Early diagnosis and a combination of treatments, including minoxidil and finasteride, are recommended for managing hair loss in India.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Finasteride treats baldness but may cause lasting sexual side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

No definitive link between finasteride and male breast cancer, but further research is needed.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.